PharmaCielo Ltd.
PCLO.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -2.66M | -2.59M | -3.31M | -4.67M | -5.61M |
| Total Depreciation and Amortization | 1.07M | 1.20M | 886.10K | 778.10K | 899.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -538.50K | -635.80K | 2.11M | 2.67M | 3.16M |
| Change in Net Operating Assets | -2.89M | -1.32M | -575.80K | -174.90K | 2.30M |
| Cash from Operations | -5.02M | -3.33M | -885.70K | -1.40M | 753.00K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | 7.28M | 7.25M | 4.84M | 5.38M | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 22.90K | 22.90K | 22.90K |
| Cash from Investing | 7.28M | 7.25M | 4.86M | 5.40M | 22.90K |
| Total Debt Issued | 530.00K | 415.00K | 705.00K | 1.07M | 1.66M |
| Total Debt Repaid | -3.57M | -5.85M | -5.94M | -6.24M | -2.64M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -2.21M | -3.94M | -3.81M | -3.76M | -718.80K |
| Foreign Exchange rate Adjustments | 11.80K | 1.90K | 17.40K | 12.30K | 1.60K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 51.70K | -24.90K | 186.40K | 250.60K | 58.60K |